NETs: organ-related epigenetic derangements and potential clinical applications.
about
Tumor immunotherapy: drug-induced neoantigens (xenogenization) and immune checkpoint inhibitors.Antineoplastic effects of histone deacetylase inhibitors in neuroendocrine cancer cells are mediated through transcriptional regulation of Notch1 by activator protein 1.Clinical and Preclinical Advances in Gastroenteropancreatic Neuroendocrine Tumor Therapy.Molecular challenges of neuroendocrine tumors.Update in the Therapy of Advanced Neuroendocrine Tumors.
P2860
NETs: organ-related epigenetic derangements and potential clinical applications.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
NETs: organ-related epigenetic derangements and potential clinical applications.
@en
type
label
NETs: organ-related epigenetic derangements and potential clinical applications.
@en
prefLabel
NETs: organ-related epigenetic derangements and potential clinical applications.
@en
P2093
P2860
P921
P356
P1433
P1476
NETs: organ-related epigenetic derangements and potential clinical applications.
@en
P2093
Francesca Maria Rizzo
Mauro Cives
Valeria Simone
P2860
P304
57414-57429
P356
10.18632/ONCOTARGET.10598
P407
P5008
P577
2016-07-13T00:00:00Z
2016-08-30T00:00:00Z